Minimal Residual Disease in Multiple Myeloma: Past, Present, and Future

SIMPLE SUMMARY: The assessment of responses is critical in patients diagnosed with multiple myeloma. Nowadays, one of the most informative parameters to discriminate responses to treatment and prognosis is minimal residual disease (MRD). Several strategies may be used to detect and quantify MRD; som...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Herrera, Alejandro, Sarasquete, María Eugenia, Jiménez, Cristina, Puig, Noemí, García-Sanz, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377959/
https://www.ncbi.nlm.nih.gov/pubmed/37509348
http://dx.doi.org/10.3390/cancers15143687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377959/
https://www.ncbi.nlm.nih.gov/pubmed/37509348
http://dx.doi.org/10.3390/cancers15143687

Ejemplares similares